Related Experiment Video
Updated: Feb 4, 2026

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
Jung Wook Park1, John K Lee2, Katherine M Sheu3
1Department of Microbiology, Immunology, and Molecular Genetics, University of California-Los Angeles, Los Angeles, CA 90095, USA.
Abstract:
The use of potent therapies inhibiting critical oncogenic pathways active in epithelial cancers has led to multiple resistance mechanisms, including the development of highly aggressive, small cell neuroendocrine carcinoma (SCNC). SCNC patients have a dismal prognosis due in part to a limited understanding of the molecular mechanisms driving this malignancy and the lack of effective treatments. Here, we demonstrate that a common set of defined oncogenic drivers reproducibly reprograms normal human prostate and lung epithelial cells to small cell prostate cancer (SCPC) and small cell lung cancer (SCLC), respectively. We identify shared active transcription factor binding regions in the reprogrammed prostate and lung SCNCs by integrative analyses of epigenetic and transcriptional landscapes. These results suggest that neuroendocrine cancers arising from distinct epithelial tissues may share common vulnerabilities that could be exploited for the development of drugs targeting SCNCs.
Insights
Potent cancer therapies can cause aggressive small cell neuroendocrine carcinoma (SCNC). Researchers found common drivers reprogramming normal cells to SCNC, suggesting shared vulnerabilities for new drug development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Advanced cancer therapies targeting oncogenic pathways can induce resistance, leading to aggressive small cell neuroendocrine carcinoma (SCNC).
- SCNC presents a poor prognosis due to limited understanding of its molecular drivers and lack of effective treatments.
Purpose of the Study:
- To investigate the molecular mechanisms underlying SCNC development.
- To identify shared vulnerabilities in SCNC arising from different epithelial tissues.
Main Methods:
- Reprogramming of normal human prostate and lung epithelial cells using defined oncogenic drivers.
- Integrative analysis of epigenetic and transcriptional landscapes in reprogrammed cells.
- Identification of shared active transcription factor binding regions.
Main Results:
- Defined oncogenic drivers reproducibly reprogrammed normal prostate and lung epithelial cells into small cell prostate cancer (SCPC) and small cell lung cancer (SCLC), respectively.
- Shared active transcription factor binding regions were identified in both reprogrammed SCPC and SCLC.
- These findings indicate common molecular underpinnings in SCNCs derived from distinct tissues.
Conclusions:
- SCNCs originating from different epithelial tissues may share common vulnerabilities.
- These shared vulnerabilities could be therapeutically targeted for novel SCNC drug development.
More Related Videos
Related Concept Videos
Epithelial Tissues and Their Functions
Epithelial tissues provide the body's first line of protection from physical,...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Common Ion Effect
Classification of Epithelial Tissues: Overview
Based on the number of cell layers,...
Classification of Epithelial Tissues: Stratified Epithelium
Classification of Epithelial Tissues: Glandular Epithelium
Multicellular glands are formed during early development when epithelial budding...

